ÂÜÀòÂÒÂ×

Karol Estrada, MSc, PhD has extensive work experience in the field of genomics and statistical genetics. They are currently serving as the VP Translational Genomics at Maze Therapeutics. Prior to this, Karol held roles at various organizations, including Brandeis University, BioMarin Pharmaceutical Inc., Biogen, Broad Institute of MIT and Harvard, Erasmus University Medical Center, National Institute of Genomic Medicine, Grupo Iusacell, Grupo Elektra, and Qnet. Throughout their career, Karol has been involved in a wide range of responsibilities, such as teaching, leading research teams, analyzing large-scale genetic resources, identifying drug targets, and publishing scientific papers. They have also been recognized with several awards for their contributions to the field.

Karol Estrada holds an impressive academic background in the field of genetic epidemiology, computer science, and drug and medical device development. Karol began their educational journey in 1997 at Tecnológico de Monterrey, where they pursued a Bachelor of Science degree in Computer Systems Engineering, completing their studies in 2001. Following this, from 2002 to 2004, Karol pursued a Master of Science degree in Computer Science at Tecnológico de Monterrey.

Karol continued to pursue higher education, and from 2008 to 2012, they attended Erasmus University Rotterdam, where they obtained their Ph.D. in Genetic Epidemiology. During this period, they focused on the study of how genetic factors interact with epidemiological risks to contribute to the development of diseases.

Furthermore, Karol Estrada has also obtained a Professional Certificate in Drug and Medical Device Development. In December 2019, they completed the program at MIT xPRO, offered by the Massachusetts Institute of Technology. Through this certification, they gained comprehensive knowledge and expertise in the field of drug and medical device development.

With their educational background and certifications, Karol Estrada exhibits a diverse skillset encompassing computer science, genetic epidemiology, and drug and medical device development.